876 results on '"Pizza, Mariagrazia"'
Search Results
2. The overlooked bacterial pandemic
3. Scientists’ call to action: Microbes, planetary health, and the Sustainable Development Goals
4. A next-generation GMMA-based vaccine candidate to fight shigellosis
5. Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS)
6. OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans
7. Animal models in vaccinology: state of the art and future perspectives for an animal-free approach
8. Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.
9. Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096
10. Standing the test of COVID-19: charting the new frontiers of medicine
11. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies
12. The Secretome landscape of Escherichia coli O157:H7: Deciphering the cell-surface, outer membrane vesicle and extracellular subproteomes
13. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia
14. Enhancing a multi-purpose artificial urine for culture and gene expression studies of uropathogenic Escherichia coli strains
15. 4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
16. Antibodies, epicenter of SARS-CoV-2 immunology
17. Vaccines Against Escherichia coli
18. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
19. Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
20. The overlooked bacterial pandemic
21. Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens
22. Enhancing a multipurpose artificial urine for culture and gene expression studies of uropathogenic Escherichia coli strains
23. Differential biotin labelling of the cell envelope proteins in lipopolysaccharidic diderm bacteria: Exploring the proteosurfaceome of Escherichia coli using sulfo-NHS-SS-biotin and sulfo-NHS-PEG4-bismannose-SS-biotin
24. Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents
25. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model
26. Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007–08 and 2014–15: a qualitative and quantitative assessment
27. Identification of Vaccine Candidates against Serogroup B Meningococcus by Whole-Genome Sequencing
28. Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58
29. Analytical Control Strategy of Bacterial Subunit Vaccines
30. KDEL Receptor (Erd2p)-Mediated Retrograde Transport of the Cholera Toxin A Subunit from the Golgi Involves COPI, p23, and the COOH Terminus of Erd2p
31. Specific Proteomic Identification of Collagen-Binding Proteins in Escherichia coli O157:H7: Characterisation of OmpA as a Potent Vaccine Antigen
32. Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens
33. Functional assays to evaluate antibody-mediated responses against Shigella: a review
34. Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
35. Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli
36. Vaccines for a sustainable planet
37. Editorial overview: Vaccines
38. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
39. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A
40. Bacterial Toxins
41. Design of New Vaccines in the Genomic and Post-genomic Era
42. Faculty Opinions recommendation of A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
43. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway
44. Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody
45. Vaccines, new opportunities for a new society
46. Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure
47. Metronidazole Resistance in Helicobacter pylori [with Reply]
48. Characterization of Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-Antigens in Human Sera.
49. Bacterial Toxins
50. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.